Dokoshi, Tatsuya http://orcid.org/0000-0003-3678-6781
Chen, Yang
Cavagnero, Kellen J. http://orcid.org/0000-0003-4160-6394
Rahman, Gibraan
Hakim, Daniel
Brinton, Samantha
Schwarz, Hana http://orcid.org/0009-0002-4158-2847
Brown, Elizabeth A.
O’Neill, Alan
Nakamura, Yoshiyuki
Li, Fengwu
Salzman, Nita H. http://orcid.org/0000-0003-0939-6139
Knight, Rob
Gallo, Richard L. http://orcid.org/0000-0002-1401-7861
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R37AI052453)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK121760)
Article History
Received: 26 July 2023
Accepted: 20 March 2024
First Online: 8 April 2024
Competing interests
: Ethics and Inclusion statement: In conducting this research, we adhered to ethical principles and embraced inclusivity throughout the study. The study received approval from the local ethics review committee, and participant safety and well-being were paramount, with provisions in place to address potential risks. R.L.G. is a co-founder, scientific advisor, consultant, and equity holder of MatriSys Biosciences and is a consultant who receives income and equity in Sente. R.K. is a scientific advisory board member, and consultant for BiomeSense, Inc., has equity, and receives income. He is a scientific advisory board member and has equity in GenCirq. He is a consultant and scientific advisory board member for DayTwo, and receives income. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. He is a cofounder of Micronoma, and has equity and is a scientific advisory board member. The remaining authors declare no competing interests.